Author Archives: Charles Moore

Allergan and Heptares Announce Alzheimer’s Disease Treatment R&D and Commercialization Partnership

Dublin, Ireland-based global pharmaceutical company Allergan and Heptares Therapeutics, a clinical-stage pharmaceutical company whose proprietary technologies have created new medicines with the potential to transform Alzheimer’s disease, have entered into a global research and development and commercialization partnership for the treatment of Alzheimer’s…

Alzheimer’s Texas Cuts Ties with National Group Over Funding Dispute

Austin-based Alzheimer’s Association Capital of Texas Chapter (known as Alzheimer’s Texas) announced that the organization has separated from the national organization, based in Chicago. The organization, a leader in Alzheimer’s care, education, and support in Central Texas, and the state’s pre-eminent force for new funding for Alzheimer’s disease and dementia research, says that the…

MitoQ Proprietary Antioxidant Selected For Study By National Institute of Aging’s Interventions Testing Program

MitoQ, the world’s first antioxidant formula demonstrating ability to penetrate mitochondria in order to deliver antioxidants in meaningful levels, has been selected for the USA’s National Institute of Aging’s (NIA) Interventions Testing Program (ITP) — an internationally recognized anti-aging testing program funded by the US Government — reports…

Alzheimer’s Disease Markers Found in Speech Patterns

Scientists with the University Health Network (UHN) in Toronto, Canada, have discovered a method of diagnosing Alzheimer’s disease with more than 80 percent accuracy. The innovative technique evaluates the interplay between four linguistic factors, and the researchers are developing automated technology to detect these impairments. The study, led by…

Brain Implant Could Help People With Memory Loss

Researchers at University of Southern California at Los Angeles (USC) Viterbi School of Engineering and Wake Forest Baptist Medical Center in Winston-Salem, North Carolina have developed a brain prosthesis designed to help individuals suffering from memory loss associated with Alzheimer’s Disease (AD) and other forms of dementia form new…

Aduhelm Approved